共 137 条
[61]
Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides:: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase
[J].
Levell, J
;
Astles, P
;
Eastwood, P
;
Cairns, J
;
Houille, O
;
Aldous, S
;
Merriman, G
;
Whiteley, B
;
Pribish, J
;
Czekaj, M
;
Liang, GY
;
Maignan, S
;
Guilloteau, JP
;
Dupuy, A
;
Davidson, J
;
Harrison, T
;
Morley, A
;
Watson, S
;
Fenton, G
;
McCarthy, C
;
Romano, J
;
Mathew, R
;
Engers, D
;
Gardyan, M
;
Sides, K
;
Kwong, J
;
Tsay, J
;
Rebello, S
;
Shen, LD
;
Wang, J
;
Luo, YY
;
Giardino, O
;
Lim, HK
;
Smith, K
;
Pauls, H
.
BIOORGANIC & MEDICINAL CHEMISTRY,
2005, 13 (08)
:2859-2872

Levell, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Astles, P
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Eastwood, P
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Cairns, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Houille, O
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Aldous, S
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Merriman, G
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Whiteley, B
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Pribish, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Czekaj, M
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Liang, GY
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Maignan, S
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Guilloteau, JP
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Dupuy, A
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Davidson, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Harrison, T
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Morley, A
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Watson, S
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Fenton, G
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

McCarthy, C
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Romano, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Mathew, R
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Engers, D
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Gardyan, M
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Sides, K
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Kwong, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Tsay, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Rebello, S
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Shen, LD
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Wang, J
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Luo, YY
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Giardino, O
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Lim, HK
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Smith, K
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA

Pauls, H
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA Aventis Pharmaceut, Drug Innovat & Approval, Bridgewater, NJ 08807 USA
[62]
Is the critical role of loop 3 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase in catalysis due to loop-3 residues arginine-84 and tryptophan-89?: Site-directed mutagenesis, biochemical, and crystallographic studies
[J].
Li, Y
;
Blaszczyk, J
;
Wu, Y
;
Shi, GB
;
Ji, XH
;
Yan, HG
.
BIOCHEMISTRY,
2005, 44 (24)
:8590-8599

Li, Y
论文数: 0 引用数: 0
h-index: 0
机构: Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA

Blaszczyk, J
论文数: 0 引用数: 0
h-index: 0
机构: Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA

Wu, Y
论文数: 0 引用数: 0
h-index: 0
机构: Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA

Shi, GB
论文数: 0 引用数: 0
h-index: 0
机构: Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA

Ji, XH
论文数: 0 引用数: 0
h-index: 0
机构:
Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA

Yan, HG
论文数: 0 引用数: 0
h-index: 0
机构: Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA
[63]
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
[J].
Lipinski, CA
;
Lombardo, F
;
Dominy, BW
;
Feeney, PJ
.
ADVANCED DRUG DELIVERY REVIEWS,
1997, 23 (1-3)
:3-25

Lipinski, CA
论文数: 0 引用数: 0
h-index: 0
机构: Central Research Division, Pfizer Inc., Groton

Lombardo, F
论文数: 0 引用数: 0
h-index: 0
机构: Central Research Division, Pfizer Inc., Groton

Dominy, BW
论文数: 0 引用数: 0
h-index: 0
机构: Central Research Division, Pfizer Inc., Groton

Feeney, PJ
论文数: 0 引用数: 0
h-index: 0
机构: Central Research Division, Pfizer Inc., Groton
[64]
A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neurarninidase
[J].
Lommer, BS
;
Ali, SM
;
Bajpai, SN
;
Brouillette, WJ
;
Air, GM
;
Luo, M
.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY,
2004, 60
:1017-1023

Lommer, BS
论文数: 0 引用数: 0
h-index: 0
机构: Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

Ali, SM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

Bajpai, SN
论文数: 0 引用数: 0
h-index: 0
机构: Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

Brouillette, WJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

Air, GM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA

Luo, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[65]
Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor
[J].
Luic, M
;
Koellner, G
;
Yokomatsu, T
;
Shibuya, S
;
Bzowska, A
.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY,
2004, 60
:1417-1424

Luic, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Warsaw, Inst Expt Biol, Dept Biophys, PL-02089 Warsaw, Poland

Koellner, G
论文数: 0 引用数: 0
h-index: 0
机构: Univ Warsaw, Inst Expt Biol, Dept Biophys, PL-02089 Warsaw, Poland

Yokomatsu, T
论文数: 0 引用数: 0
h-index: 0
机构: Univ Warsaw, Inst Expt Biol, Dept Biophys, PL-02089 Warsaw, Poland

Shibuya, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Warsaw, Inst Expt Biol, Dept Biophys, PL-02089 Warsaw, Poland

论文数: 引用数:
h-index:
机构:
[66]
Progesterone receptor ligand binding pocket flexibility: Crystal structures of the norethindrone and mometasone furoate complexes
[J].
Madauss, KP
;
Deng, SJ
;
Austin, RJH
;
Lambert, MH
;
McLay, I
;
Pritchard, J
;
Short, SA
;
Stewart, EL
;
Uings, IJ
;
Williams, SP
.
JOURNAL OF MEDICINAL CHEMISTRY,
2004, 47 (13)
:3381-3387

Madauss, KP
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Deng, SJ
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Austin, RJH
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Lambert, MH
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

McLay, I
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Pritchard, J
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Short, SA
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Stewart, EL
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Uings, IJ
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA

Williams, SP
论文数: 0 引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA
[67]
Imatinib: a selective tyrosine kinase inhibitor
[J].
Manley, PW
;
Cowan-Jacob, SW
;
Buchdunger, E
;
Fabbro, D
;
Fendrich, G
;
Furet, P
;
Meyer, T
;
Zimmermann, J
.
EUROPEAN JOURNAL OF CANCER,
2002, 38
:S19-S27

Manley, PW
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Cowan-Jacob, SW
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Buchdunger, E
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Fabbro, D
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Fendrich, G
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Furet, P
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Meyer, T
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland

Zimmermann, J
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma Ltd, Basel, Switzerland Novartis Pharma Ltd, Basel, Switzerland
[68]
Mechanism of CDK5/p25 binding by CDK inhibitors
[J].
Mapelli, M
;
Massimiliano, L
;
Crovace, C
;
Seeliger, MA
;
Tsai, LH
;
Meijer, L
;
Musacchio, A
.
JOURNAL OF MEDICINAL CHEMISTRY,
2005, 48 (03)
:671-679

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Crovace, C
论文数: 0 引用数: 0
h-index: 0
机构: European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy

Seeliger, MA
论文数: 0 引用数: 0
h-index: 0
机构: European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy

Tsai, LH
论文数: 0 引用数: 0
h-index: 0
机构: European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy

Meijer, L
论文数: 0 引用数: 0
h-index: 0
机构: European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy

Musacchio, A
论文数: 0 引用数: 0
h-index: 0
机构:
European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy European Inst Oncol, Dept Expt Oncol, Struct Biol Unit, Via Ripamonti 435, I-20141 Milan, Italy
[69]
Getting the adrenaline going: Crystal structure of the adrenaline-synthesizing enzyme PNMT
[J].
Martin, JL
;
Begun, J
;
McLeish, MJ
;
Caine, JM
;
Grunewald, GL
.
STRUCTURE,
2001, 9 (10)
:977-985

Martin, JL
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia

Begun, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia

McLeish, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia

Caine, JM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia

Grunewald, GL
论文数: 0 引用数: 0
h-index: 0
机构: Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia
[70]
Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa
[J].
Matter, H
;
Defossa, E
;
Heinelt, U
;
Blohm, PM
;
Schneider, D
;
Müller, A
;
Herok, S
;
Schreuder, H
;
Liesum, A
;
Brachvogel, V
;
Lönze, P
;
Walser, A
;
Al-Obeidi, F
;
Wildgoose, P
.
JOURNAL OF MEDICINAL CHEMISTRY,
2002, 45 (13)
:2749-2769

Matter, H
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Defossa, E
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Heinelt, U
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Blohm, PM
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Schneider, D
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Müller, A
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Herok, S
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Schreuder, H
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Liesum, A
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Brachvogel, V
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Lönze, P
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Walser, A
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Al-Obeidi, F
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany

Wildgoose, P
论文数: 0 引用数: 0
h-index: 0
机构:
Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany Aventis Pharma Deutschland GmbH, DI&A, Mol Modeling,Med Chem, Struct Biol,DG Thrombosis & Degenerat Joint Dis, D-65926 Frankfurt, Germany